News
Company News: BioNTech Secures USD 270 Million in Series A Financing
BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, today announced it has completed a USD 270 million Series A round of financing. The Company previously completed a seed round fundraising in 2008 concurrent with its founding.
Company News: ISA Pharmaceuticals to Present at the Biotech Showcase™ Annual Conference 2018
ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, today announced that it will present at Biotech Showcase™ 2018, to be held January 8–10 at the Hilton San Francisco Union Square.
Company News: BioNTech to Present at 36th Annual J.P. Morgan Healthcare Conference
BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that Sean Marett, COO of BioNTech, will be presenting at the 36th Annual J.P. Morgan Healthcare Conference that is being held in San Francisco, CA from January 8-11, 2018. The Company’s presentation is scheduled for Tuesday, January 9 at 9:00 AM Pacific Standard Time.